{"hands_on_practices": [{"introduction": "This exercise introduces a key experimental technique, Fluorescence In Situ Hybridization (FISH), that allows us to directly measure the outcomes of meiosis in a translocation carrier. While theoretical models provide a framework, real-world segregation can be biased. By analyzing sperm FISH data [@problem_id:5084181], you will work backward to deduce the actual frequencies of alternate and adjacent segregation, providing an empirical basis for genetic counseling.", "problem": "A man is heterozygous for a reciprocal translocation between two autosomes, described cytogenetically as `t(4;11)(q21;q23)`. During meiosis I, the four homologous chromosome arms pair to form a quadrivalent, which can resolve by alternate segregation (yielding balanced gametes) or by adjacent-1 segregation (yielding duplication/deficiency of the translocated segments and therefore unbalanced gametes). Adjacent-2 segregation (homologous centromeres to the same pole) is empirically rare, and $3:1$ segregation produces hyperhaploid nuclei that are excluded by the laboratory’s gating. A Fluorescence In Situ Hybridization (FISH) assay was conducted on ejaculated sperm using locus-specific probes to the distal $4q$ and distal $11q$ segments and centromeric probes to $4$ and $11$, scoring only haploid nuclei. Among $n = 2000$ sperm nuclei, $800$ were unbalanced by FISH ($40\\%$), and among the entire set, the signature consistent with adjacent-2 was observed in $n = 20$ nuclei ($1\\%$). Assume that the assay detects unbalanced products of adjacent-1 and adjacent-2 with high sensitivity and that $3:1$ products are excluded by DNA-content gating.\n\nBased solely on the core definitions of meiotic segregation in reciprocal translocations and the observations above, which statement best describes the likely segregation bias between alternate and adjacent-1 in this translocation case?\n\nA. The data indicate a strong preference for alternate segregation, with $f_{\\text{alt}} \\ge 80\\%$ and $f_{\\text{adj1}} \\le 20\\%$.\n\nB. The data indicate a moderate preference for alternate segregation, with $f_{\\text{alt}} \\approx 60\\%$ and $f_{\\text{adj1}} \\approx 39\\%$ to $40\\%$, after accounting for a small adjacent-2 component.\n\nC. The data indicate no orientation bias, with $f_{\\text{alt}} \\approx f_{\\text{adj1}} \\approx 50\\%$, because unbalanced products predominantly arise from $3:1$ events.\n\nD. The data indicate a preference for adjacent-1 segregation, with $f_{\\text{adj1}} \\ge 60\\%$, because the unbalanced fraction is $40\\%$.", "solution": "The problem requires calculating the frequencies of alternate ($f_{\\text{alt}}$) and adjacent-1 ($f_{\\text{adj1}}$) segregation from sperm FISH data. The analysis excludes $3:1$ segregation products, so the total scored sample of $n = 2000$ nuclei represents only the outcomes of $2:2$ segregation (alternate, adjacent-1, and adjacent-2).\n\nThe total frequency of events within the scored sample can be expressed as:\n$$ f_{\\text{total}} = f_{\\text{alt}} + f_{\\text{adj1}} + f_{\\text{adj2}} = 100\\% $$\n\nFrom the data provided:\n1.  The total frequency of unbalanced gametes is given as $40\\%$. These gametes arise from adjacent-1 and adjacent-2 segregation.\n    $$ f_{\\text{unbalanced}} = f_{\\text{adj1}} + f_{\\text{adj2}} = 40\\% $$\n2.  The frequency of adjacent-2 segregation is given as $f_{\\text{adj2}} = 1\\%$.\n\nUsing these values, we can solve for the frequency of adjacent-1 segregation:\n$$ f_{\\text{adj1}} = f_{\\text{unbalanced}} - f_{\\text{adj2}} = 40\\% - 1\\% = 39\\% $$\n\nThe frequency of balanced gametes, which arise only from alternate segregation, is the complement of the unbalanced fraction:\n$$ f_{\\text{alt}} = 100\\% - f_{\\text{unbalanced}} = 100\\% - 40\\% = 60\\% $$\n\nOur calculated frequencies are $f_{\\text{alt}} = 60\\%$ and $f_{\\text{adj1}} = 39\\%$. This indicates a moderate preference for alternate segregation over adjacent-1 segregation ($60\\%$ vs. $39\\%$).\n\nWe can now evaluate the options:\n*   A is incorrect because our calculated $f_{\\text{alt}}$ is $60\\%$, not $\\ge 80\\%$.\n*   B is correct because our calculated frequencies ($f_{\\text{alt}} = 60\\%$, $f_{\\text{adj1}} = 39\\%$) match the stated approximations ($f_{\\text{alt}} \\approx 60\\%$ and $f_{\\text{adj1}} \\approx 39\\%$ to $40\\%$).\n*   C is incorrect because the frequencies are not approximately equal, and it incorrectly invokes $3:1$ segregation, which was excluded from the analysis.\n*   D is incorrect because the data show a preference for alternate segregation, not adjacent-1.", "answer": "$$\\boxed{B}$$", "id": "5084181"}, {"introduction": "Building on the principles of meiotic segregation, this exercise shifts the focus to calculating the probability of a specific clinical outcome for the offspring of a carrier. You will model the meiotic outcomes for a Robertsonian translocation, the most common type of structural rearrangement in humans. This practice [@problem_id:5084189] requires you to synthesize segregation probabilities, fetal viability statistics, and independent background risks to determine a clinically relevant recurrence risk.", "problem": "A phenotypically normal woman is heterozygous for a Robertsonian translocation between chromosomes $13$ and $14$, denoted `rob(13;14)`. She plans a pregnancy with a karyotypically normal partner. Assume the following foundational facts and model assumptions:\n\n- In meiosis I, the homologous centromeres for the acrocentric chromosomes $13$ and $14$ and the derivative chromosome `der(13;14)` form a trivalent. A trivalent can orient in three ways at anaphase I, each with equal probability under random orientation, sending either `{der(13;14), 13}` versus `{14}`, or `{der(13;14), 14}` versus `{13}`, or `{13, 14}` versus `{der(13;14)}` to opposite poles.\n- Each of these three orientations yields two reciprocal gamete types with equal frequency, so each of the six possible gamete types has probability $1/6$.\n- After fertilization by a normal gamete, only the following conceptuses are viable to live birth with nonzero probability: normal disomy for both $13$ and $14$, balanced `rob(13;14)` carriers, and trisomy $13$ (Patau syndrome). Conceptuses with monosomy $13$, trisomy $14$, or monosomy $14$ do not survive to live birth.\n- Let $s_{13}$ denote the fraction of trisomy $13$ conceptions that survive to live birth. Use $s_{13} = 0.020$.\n- Let $b_{21}$ denote the maternal age-adjusted background risk (at live birth) for free trisomy $21$ (Down syndrome) due to meiotic nondisjunction, independent of the translocation. Use $b_{21} = 5.8 \\times 10^{-3}$ (appropriate for maternal age $36$).\n- For “Robertsonian Down syndrome” (translocation Down syndrome caused by `rob(14;21)` or `rob(21;21)`), assume the risk contributed by `rob(13;14)` segregation is $0$ (ignore extremely rare de novo Robertsonian events involving chromosome $21$).\n\nUsing only the core definitions of meiotic trivalent formation, random orientation, and the viability categories above, derive from first principles the probability at live birth for each of the following outcomes in the offspring of this `rob(13;14)` carrier: trisomy $21$, trisomy $13$, and Robertsonian Down syndrome. Express your three final risks as decimal fractions. Round your three answers to four significant figures.", "solution": "This problem requires calculating live birth risks for an offspring of a `rob(13;14)` translocation carrier. The calculation is conditioned on a live birth occurring.\n\n**1. Analyze Meiotic Segregation and Zygote Formation**\nThe problem states a model with six possible maternal gamete types, each with a formation probability of $1/6$. After fertilization by a normal gamete (containing one chromosome 13 and one 14), these produce six types of zygotes:\n*   **Gamete {13, 14}** → Normal zygote. **Viable** to term.\n*   **Gamete {der(13;14)}** → Balanced carrier zygote. **Viable** to term.\n*   **Gamete {der(13;14), 13}** → Trisomy 13 zygote. Viable to term with probability $s_{13}$.\n*   **Gamete {14}** → Monosomy 13 zygote. **Not viable**.\n*   **Gamete {der(13;14), 14}** → Trisomy 14 zygote. **Not viable**.\n*   **Gamete {13}** → Monosomy 14 zygote. **Not viable**.\n\n**2. Calculate the Total Probability of a Live Birth**\nThe risk calculation is conditioned on a live birth. We must first determine the total probability of a live birth, $P(L)$, by summing the probabilities of all pathways leading to a live birth.\n*   Probability of a normal live birth: $1/6 \\times 1 = 1/6$\n*   Probability of a balanced carrier live birth: $1/6 \\times 1 = 1/6$\n*   Probability of a trisomy 13 live birth: $1/6 \\times s_{13} = 1/6 \\times 0.020$\n\nThe total probability of any live birth is the sum of these:\n$$ P(L) = \\frac{1}{6} + \\frac{1}{6} + \\frac{0.020}{6} = \\frac{2 + 0.020}{6} = \\frac{2.020}{6} $$\nThis value will be the denominator for calculating the conditional probabilities (risks at live birth).\n\n**3. Calculate Specific Risks at Live Birth**\n\n*   **Risk of Trisomy 13:** This is the probability of having a trisomy 13 live birth, divided by the total probability of any live birth.\n    $$ P(T_{13}|L) = \\frac{P(\\text{Trisomy 13 live birth})}{P(L)} = \\frac{(1/6) \\times s_{13}}{(2+s_{13})/6} = \\frac{s_{13}}{2+s_{13}} $$\n    $$ P(T_{13}|L) = \\frac{0.020}{2 + 0.020} = \\frac{0.020}{2.020} \\approx 0.00990099... $$\n    Rounded to four significant figures, the risk is **$0.009901$**.\n\n*   **Risk of Trisomy 21:** The problem states this risk is independent of the translocation and is equal to the given maternal age-adjusted background risk, $b_{21}$.\n    $$ P(T_{21}|L) = b_{21} = 5.8 \\times 10^{-3} = 0.0058 $$\n    Rounded to four significant figures, the risk is **$0.005800$**.\n\n*   **Risk of Robertsonian Down Syndrome:** This condition is caused by a translocation involving chromosome 21 (e.g., `rob(14;21)`). The mother has a `rob(13;14)` translocation. The problem states to assume the risk from this translocation is 0.\n    The risk is **$0.0000$**.\n\nThe final probabilities in the requested order (Trisomy 21, Trisomy 13, Robertsonian Down Syndrome) are $0.005800$, $0.009901$, and $0.0000$.", "answer": "$$\\boxed{\\begin{pmatrix} 0.005800 & 0.009901 & 0.0000 \\end{pmatrix}}$$", "id": "5084189"}, {"introduction": "The final step in understanding structural abnormalities is to appreciate *why* they cause disease. This practice moves beyond the mechanics of meiosis to the fundamental principles of gene dosage. By comparing a chromosomal deletion to its reciprocal duplication [@problem_id:5084199], you will apply concepts like haploinsufficiency to construct a logical argument about expected phenotypic severity, a core skill in clinical variant interpretation.", "problem": "A clinical genetics team identifies in one patient a heterozygous interstitial deletion of size $5$ Mb on an autosome. High-resolution sequencing shows that the deleted interval encompasses $5$ genes that have documented haploinsufficiency, meaning that one functional allele is not sufficient to maintain normal phenotype. A second patient carries a heterozygous duplication of the same $5$ Mb interval, with the same $5$ genes increased in copy number. Both variants arose as recurrent Copy Number Variations (CNVs), consistent with formation by Non-Allelic Homologous Recombination (NAHR) between flanking low-copy repeats. The clinical team asks you to reason, from first principles of gene dosage and meiotic behavior of structural variants, which scenario is expected to produce greater phenotypic severity and why. Assume no prior evidence that these $5$ genes are triplosensitive, and that background deleterious variants in the population are rare but nonzero. Which option best constructs the rationale?\n\nA. The deletion is expected to be more severe because it reduces gene copy number from $2$ to $1$ for $5$ haploinsufficient genes, likely dropping below functional dosage thresholds; it can also unmask recessive pathogenic variants on the remaining allele and remove cis-regulatory elements within the $5$ Mb region. By contrast, the duplication raises gene copy number from $2$ to $3$, which is frequently tolerated unless the genes are triplosensitive, and the meiotic pairing consequences of such CNVs do not, by themselves, increase clinical severity in the heterozygous carrier.\n\nB. The duplication is expected to be more severe because increasing dosage universally creates dominant-negative effects across all $5$ genes, whereas a deletion is buffered by homeostatic upregulation that restores expression to $100\\%$.\n\nC. The deletion and duplication should have equivalent severity because changing dosage by $\\pm 1$ copy produces symmetric, linear changes in pathway outputs around the wild-type state, making loss and gain of one copy equally disruptive.\n\nD. The duplication is expected to be more severe because, in duplication heterozygotes, meiotic recombination frequently produces dicentric bridges and widespread somatic aneuploidy, whereas deletions do not.\n\nE. The deletion is expected to be less severe because haploinsufficient genes, by definition, tolerate $50\\%$ dosage, while duplications more often disrupt Topologically Associating Domains (TADs), causing enhancer hijacking and stronger misexpression than deletions.", "solution": "This problem asks for a reasoned comparison of the expected phenotypic severity between a heterozygous deletion and a heterozygous duplication of the same $5$ Mb genomic region. The reasoning should be based on first principles of gene dosage.\n\n1.  **Analyze the Deletion:** The deleted region contains five genes that are known to be **haploinsufficient**. By definition, haploinsufficiency means that having only one functional copy of a gene (resulting in approximately $50\\%$ of the normal protein level) is insufficient for a normal phenotype and causes disease. Therefore, the deletion is expected to be pathogenic due to the reduced dosage of these five critical genes. A secondary mechanism that can increase severity is the **unmasking of recessive alleles**: if the patient carries a rare, non-functional recessive allele on the homologous chromosome in this region, the deletion will unmask its effect.\n\n2.  **Analyze the Duplication:** The duplication increases the copy number of the same five genes from two to three, resulting in approximately $150\\%$ of the normal protein level. Pathogenicity due to increased dosage is known as **triplosensitivity**. The problem explicitly states there is \"no prior evidence that these 5 genes are triplosensitive.\" While gene overdose can be harmful, it is not guaranteed to be. Biological systems are often more tolerant of a moderate increase in gene product than a decrease, especially a decrease below a critical haploinsufficiency threshold. Thus, the pathogenicity of the duplication is uncertain.\n\n3.  **Compare Severity:** The deletion's pathogenicity is nearly certain due to the documented haploinsufficiency of the affected genes. The duplication's pathogenicity is conditional and unknown. Therefore, based on the provided information, the deletion is expected to result in a more severe phenotype. Meiotic consequences (risks for offspring) are not relevant to the clinical severity of the carrier's own phenotype.\n\n**Evaluation of Options:**\n*   **A** accurately summarizes this logic. It correctly identifies haploinsufficiency as the primary driver of severity for the deletion, includes valid secondary mechanisms (unmasking recessive variants, disruption of regulatory elements), and correctly frames the duplication's risk as conditional on triplosensitivity. It also correctly dismisses meiotic consequences as irrelevant to the carrier's severity.\n*   **B** is incorrect. Increased dosage of a normal gene does not cause a dominant-negative effect, and the claim that deletions are buffered by upregulation contradicts the definition of haploinsufficiency.\n*   **C** is incorrect. It assumes a simplistic and biologically unrealistic symmetric response to gene dosage changes.\n*   **D** is incorrect. It conflates meiotic (germline) events with the patient's somatic phenotype.\n*   **E** is incorrect because it contains a statement that is the opposite of the definition of haploinsufficiency (it claims haploinsufficient genes *tolerate* $50\\%$ dosage).\n\nTherefore, option A provides the most complete and accurate rationale.", "answer": "$$\\boxed{A}$$", "id": "5084199"}]}